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A mutant strain of mice suffering from hemimelia and asplenia was reported 
by Searle (1). The abnormalities  are inherited as an autosomal dominant gene 
(Dh). Asplenic mice have normal cellular immunity (2) and a depressed immuno- 
globulin synthesis (2,  3) owing to a  marked  impairment  of thymus and  bone 
marrow cell cooperation (4, 5) needed for antibody formation. 
Another mutant strain of hairless (nude) mice, discovered by Flanagan (6), is 
characterized  by congenital  athymia  (7)  which  is  inherited  as  an  autosomal 
recessive  gene  (nu).  In  addition  to  a  marked  deficiency  of thymus-derived 
lymphocytes  and  depressed  humoral  immune  response  to  thymus-dependent 
antigens,  nude  mice fail to reject grafts of normal  and  neoplastic xenogeneic 
tissues (8). 
The  availability  of these  two  mutant  strains  of mice  made  it  possible  to 
develop a unique animal model with agenesis of both the thymus and spleen by 
crossing nude with asplenic mice. Such an animal would be expected to have a 
marked impairment of both cellular and humoral immunity, thus making it an 
ideal model for heterotransplantation  as well as a variety of immunological and 
hematological studies. 
Materials  and Methods 
Mice.  The development and maintenance of the nude and asplenic colonies in our labora- 
tory has been described (2, 9). At the start of these experiments the nude and the asplenic colonies 
were in the fifth and sixth generations of inbreeding, respectively. 
To establish the asplenic-athymic colony,  a  Dh/+  female was mated with a  nu/nu male.  The 
asplenic-athymic hybrids (hereafter referred to as "lasat" mice) were obtained by backcrossing 
females heterozygous for the nu and Dh genes (nu/+, Dh/+) with their athymic father (ntYnu). 
This second mating was carried out in a  pathogen-free isolator. 
Culture of Chronic Myelogenous Leukemic (CML ) Cells.  The development and maintenance of 
the CML cell line K-562, which has the Philadelphia (Ph') chromosome and a translocation 15;17 
after more than 4 yr in culture, has been reported (10). 
Transplantation of CML Cells. The method of Peters and Hewitt (11) which takes advantage of 
the Rdvdsz effect (12) to grow transplantable tumor cells was used with slight modifications. Cells 
were obtained at passages 222 and 225 from suspension cultures and centrifuged at 800 g. The cell 
pellet was resuspended in fresh culture medium (10) at a  concentration of 50 x  10e/ml and 0.1 ml 
was mixed with 0.1 ml of solution of human fibrinogen in the same medium (100 mg/ml). The pH 
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was adjusted to 7.2 with 1.0 N NaOH and two drops of a freshly prepared bovine thrombin solution 
(1,000 U/ml) were added.  Each clot containing 5  ×  10  e CML cells was implanted subcutaneously 
(s.c.) in each of 10 lasat mice. 
Cytogenetic  Studies.  Chromosome  studies  were  routinely  made  before  transplantation.  A 
homogenous cell suspension was prepared from CML tumors and aliquots containing 10s-10  s cells 
were cultured for 7 days. Samples were taken at intervals from the cultures and karyotypes made 
by standard techniques (10). 
Antigenicity of CML Cells.  The antigenicity of cells from solid CML tumors was tested by use 
of a  primate (Macaca-speciosa) antiserum cytotoxic for the CML cell line K-562.  Each injection 
contained 5  ×  10  ~ washed CML cells in 1 ml of saline which was emulsified in 1 ml of complete 
Freund's adjuvant. Each immunization schedule consisted of threo i ml injections given on days 0, 
7, and 14. On day 21 the monkey was bled. The serum was collected, treated at 56°C for 30 min to 
inactivate complement (C), and absorbed on 30  ×  106 normal A-B blood or bone marrow cells of 
human origin, The anti-CML serum used in these experiments was from the second immunization 
schedule which  was  given with  an  interval of 3  wk.  The absorbed antisera demonstrated  C- 
dependent cytotoxicity (titer 1:640, 50% cells dead) for cultured CML cells by the trypan blue (13) 
and  51Cr-release  methods  (14).  The  cytotoxieity  from  1  ml  of immune  serum  was  completely 
removed by absorption with 30  ×  10  e CML cells.  Preimmune monkey serum was also used in 
control assays. 
General Procedures.  The diameter of the tumor was measured with a caliper with a precision 
of 0.1 ram. Tumors were removed at intervals after transplantation, weighed, fixed in formalde- 
hyde, and processed by standard techniques for light microscopy. Blood cell counts were made (9) 
weekly in all mice to determine if the growth of CML cells as a solid tumor was accompanied by an 
abnormal number of leukemic cells in the circulation. 
Results 
At present, the colony is being inbred by mating athymic males (nu/nu,  +/+) 
with asplenic sisters  (nu/+,  Dh/+).  The offspring of these matings  follow the 
typical Mendelian ratio of 25% normal (nu/+,  +/+), 25% athymic (nu/nu,  +/+), 
25%  asplenic  (nu/+,  DbJ+),  and  25%  asplenic-athymic  mice  (nu/nu,  Dh/+). 
Perinatal  deaths occurred in 7.5% of the offspring and 30 lasat mice have had 
100% survival thereafter. 
Two lasat mice are shown in Fig. 1 A. Like the nude mice, the lasat mice are 
hairless and have prominent skeletal anomalies of the hind legs, a characteristic 
of the Dh gene.  Autopsies of 20 lasat mice confirmed the agenesis of both the 
thymus and the spleen. All lymph nodes from lasat mice were hypertrophic and 
were devoid of thymus-dependent areas. The hyperplastic Peyer's patches were 
largely populated by well-differentiated lymphocytes and occupy one-third of the 
cross-section of the small  intestine.  Several small  collections of lymphoblasts 
were observed among these mature lymphocytes. The small intestine showed no 
other  alterations.  Large  accumulations  of lymphocytes  in  the  cecum  and  a 
marked hyperplasia of Kupffer's cells and other liver reticuloendothelial sinuso- 
idal lining cells were also seen in lasat mice. 
The  leukocyte counts  were similar  in  20 nude  and  10  lasat  mice  (7,000  _+ 
800/mm3).  The lasat mice had an intermediate lymphocyte to granulocyte ratio 
(53:44)  as  compared  to that  of asplenic  mice  (70:28)  or that  of athymic  mice 
(40:58).  Bone marrow cell counts revealed that lasat mice had only 8.9 -+ 0.6 x 
10  e cells per femur as compared with 15.6 -+ 0.8 ×  10  e cells for asplenic mice and 
17.0  _+  1.2  x  10  e cells for athymic mice. The diminished  number of total bone 
marrow cells was due to a  hypoplasia of lymphocytic and erythrocytic series. 
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FIG.  1.  (A) Ventral view of 60-day-old mice. Note the abnormalities of hind legs and toes, 
and/or shorter femurs (arrows).  (B) Tumor mass arising from CML cells implanted s.c. in a 
fibrin clot 31 days previously. 
mice. The anemia was more severe in lasat (6.7 _+ 0.3  x  10  e erythrocytes/mm  3) 
than  in  nude  mice  (7.8  -+  0.2  x  106  erythrocytes/mm3), whereas  a  similar 
hypoplasia of bone marrow lymphocytes was observed in both nude  I and lasat 
mice. The total serum protein concentration (6.0  _+ 0.3 g %) was similar in all 
three groups  even though lasat  mice had  50%  less  ,/-globulin than nude or 
asplenic mice. 
One  of the  most important observations made in  lasat mice has been the 
transplantation and growth of myelogenous leukemic cells with the Ph  I chromo- 
some. The incidence of"takes" was high and 9 out of 10 lasat mice given the cells 
in a fibrin clot developed similar tumor masses. The transplanted cells grow out 
from the clot after a latent period of 4-5 days. The macroscopic appearance of a 
solid tumor at 31 days is illustrated in Fig. 1 B. At this time, CML tumors were 
round or lobulated vascularized masses which reached a diameter up to 2.5 cm 
and a weight of 2-3 g. In all mice the whole tumor was excised. 
Microscopic sections (Fig. 2) revealed that CML cells proliferated into the s.c. 
tissue by growing along the blood vessels. As a result of this infiltrative growth, 
many capillaries  surrounded by the  leukemic cells  formed a  well-developed 
intratumoral vascular network.  Only a  few tumors contained small hyaline 
areas which most likely derived from the partial involution of  the original fibrin 
implant during the latent phase preceding the cell growth in vivo. Although 
leukemic cells formed a  solid nodular mass,  they did not develop cell-to-cell 
attachments. This structural arrangement created an extensive intercellular 
space connected with the perivascular areas. The random distribution of mitotic 
activity in  the  tumor cells  suggests  that  the  intercellular space  may have 
constituted a  suitable channel for the diffusion of nutrients and metabolites 
1 Bamberger,  E.  G.,  E.  A.  Machado,  and  B.  B.  Lozzio.  1975. Hematopoiesis in  hereditary 
athymic mice. Manuscript submitted for publication. 228  LOZZIO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIG. 2.  Section  of  the  CML  cell  tumor shown in  lB. Thin-walled capillary  vessels  (C)  can 
be  seen  amidst  the  proliferation  of  malignant myelogenous cells.  Hematoxylin and  eosin, x 
200. 
from the vascular network, which in turn would have accounted for the absence 
of ischemic  necrotic  areas  in  all  growing  CML  tumors  for  at  least  3  wk. 
Secondary local growth in the surrounding tissues or distant metastatic prolifer- 
ations were not observed. Imprints, stained with Giemsa, revealed the two types 
of CML cells described previously (10). 
The  clone  of the  CML  cell  line  K-562  used  for  these  experiments  showed 
significant  aneuploidy before the inoculation in lasat  mice.  The proportion  of 
cells with  various  chromosome  markers  was as follows: 6% hypodiploid cells 
with 40-45 chromosomes,  18% hyperdiploid with 48-54,  16% with 55-60,  12% 
with 61-62, and 48% near triploid (26% with 68-69 and 22% with 70-72 chromo- 
somes). All the cells showed one Ph  1 chromosome and one translocation  15;17. 
Chromosome studies of cells obtained from the tumors (Fig.  3) showed persist- 
ance  of one  Ph  ~ chromosome  and  one  translocation  15;17  identified  by  the 
Giemsa-banding  technique  as del(22)  (q12)  and t(15;17)(q21;q24),  respectively. 
The  great  majority  (79%)  of the  cells  were  nearly  triploid  (62%  with  65-69 
chromosomes and 17% with 70-77) and a minority (21%) were hyperdiploid with 
50-60  chromosomes.  Most of the  nearly  triploid  cells  analyzed  had  an  extra 
chromosome of each pair.  All 100 cells counted had the translocation  15;17 and 
the  Ph  ~ chromosome,  and  many  of them  showed several  extra  chromosomes 
number 16 and an isochromosome for the long arm of one chromosome number 7. 
Cells from  solid  CML tumors  shared common antigenic  determinants  with 
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FIG. 3.  Karyotype  of  a  near  triploid  cell  showing  a  chromosome translocation  t(15;17)  and 
the  Ph  i  chromosome.  These  chromosome markers  were  observed in  cells  from  the  patient,  in 
the  long-term cultures,  and  in  all  cells  analyzed  from  solid  CML  tumors. Another  abnormal 
chromosome  number 7  (arrows)  was  found  in  the  cells  cultured  before  and  after  transplanta- 
tion  in lasat  mice. Giemsa-binding  technique. 
against cultured CML cells were cytotoxic for 100% of the cells taken from all 
solid CML tumors tested. 
The  number  of blasts  in  the  blood  did  not  increase  although  the  mean 
leukocyte count was elevated (11,000  _+  800/ram  3) in tumor-bearing  mice.  The 
leukocyte ratio remained unchanged and no evidence of a peripheral  leukemia 
was observed up to 1 mo after transplantation  of CML cells. 
Discussion 
The development of lasat mice provides a  useful model for studies in tumor 
immunology.  The growth of CML tumors in lasat mice for more than  30 days 
without evidence of rejection confirms the lack of cellular  immunity  in these 
animals.  Since  nonimmunized  lasat  mice have  a  very low serum  level  of ~/- 
globulin it would suggest that lasat mice, as expected, have a  marked impair- 
ment of immunoglobulin synthesis as well. 
It appears  that  the source of leukemic cells and the transplantation  proce- 
dures were also essential for the successful outcome of these experiments.  We 
have observed that in suspension cultures, cell clones containing two cell types 
were  overgrown  by the  cell  type with  the  largest  chromosome  number  (10). 
Therefore,  we transplanted  a  clone of cultured CML K-562 cells with a  nearly 
triploid modal number of chromosomes. Also, the tranplantation of CML cells in 
a fibrin clot containing the medium used to grow the cells in suspension appears 
to be beneficial since the cells could not migrate from the site of implantation, 
and had the necessary nutrients. 
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were the crucial factors leading to the proliferation of CML cells in mice. We 
have suggested (10) that certain chromosomal rearrangements might be another 
cause of the increased growth rate in cultures. The fact that the great majority 
of cells from solid CML tumors were nearly triploid indicate that there was a 
clonal selection of CML cells in lasat mice, and those with the largest chromo- 
some number overgrew other leukemic cells. This finding, in turn, lends further 
support to our previous observations on the rate of proliferation of CML cells K- 
562 in cultures (10). 
In addition to the heterotransplantation of human malignancies, lasat mice 
may prove useful for other immunological investigations. Thus, the lasat mouse 
may yield new information on the development of the lymphoid system and 
offers a  new possibility for investigating the existence of structural and func- 
tional  bursal  equivalents  in  mammals  and  the  influence  of the  spleen  on 
immunocompetence. 
Summary 
A new animal model characterized by hereditary athymia and asplenia was 
used  as  a  recipient of chronic  myelogenous leukemic  (CML)  cells  with  the 
Philadelphia (Phi+) chromosome. Transplanted CML cells form solid vascular- 
ized tumors containing cells similar to those seen in the patient in a  long-term 
culture. Cells taken from the tumors were nearly triploid, retained all human 
chromosome markers,  and had the same antigenic determinant(s) as cells in 
culture. 
Received for publication  18 August 1975. 
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